Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀüÁ÷Àå°£¸· ÀýÁ¦¼ú°ú °ñ¹Ý ÃøºÎ ¸²ÇÁÀý ÀýÁ¦¼úÀÌ Á÷Àå¾ÏÀÇ ±¹¼Ò Àç¹ß°ú »ýÁ¸À²¿¡ ¹ÌÄ¡´Â ¿µÇâ Effect on the Local Recurrence and the Survival of Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection in Rectal Cancer

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2007³â 23±Ç 1È£ p.46 ~ 52
ÃÖº´°ü, ±èÇü¼ö, ¼­°æ¿ø, ÁÖÀç±Õ, ·ù¼º¿±, ¹Ú¿µ±Ô, ±èÇü·Ï, ±èµ¿ÀÇ, ±è¿µÁø,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖº´°ü ( Choi Byung-Gwan ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

±èÇü¼ö ( Kim Hyung-Soo ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¼­°æ¿ø ( Seo Kyeong-Won ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ÁÖÀç±Õ ( Ju Jae-Kyun ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
·ù¼º¿± ( Ryu Seong-Yeop ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¹Ú¿µ±Ô ( Park Young-Kyu ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±èÇü·Ï ( kim Hyeong-Rok ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±èµ¿ÀÇ ( Kim Dong-Yi ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±è¿µÁø ( Kim Young-Jin ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Purpose: One of the most common sites of recurrence after a curative resection of rectal cancer is the pelvis, and local control is a major goal of surgical treatment. The advantages of lateral pelvic lymph node dissection are regarded as questionable because lateral pelvic lymph node metastasis does not occur so frequently and because a lateral lymphadenectomy has a negative influence on the postoperative quality of life. The aim of this study was to clarify if lateral pelvic lymph node dissection (LPLD) conferred any benefit.

Methods: A total of 769 patients who underwent curative surgery for rectal cancer between 1981 and 2005 at the Department of Surgery, OOO Hospital, were reviewed retrospectively. One hundred ninety-three of these patients underwent a lateral pelvic lymph node dissection, and 576 patients had a total mesorectal excision with high ligation of the IMA.

Results: There was no difference in pathological characteristics between the two groups. Patients who underwent a lateral pelvic lymph node dissection had no statistically significant difference in terms of the 5-year survival rate at stage II and III (64% vs 65% at stage II, P=0.391; 49% vs 47% at stage III, P=0.815).

Conclusion: A lateral pelvic lymph node dissection has no advantage as part of a standard operation for rectal cancer. A total mesorectal excision alone has good local control and survival compared with a lateral pelvic lymph node dissection. J Korean Soc Coloproctol 2007;23:46-52

Å°¿öµå

Á÷Àå¾Ï;ÀüÁ÷Àå°£¸· ÀýÁ¦¼ú;°ñ¹ÝÃøºÎ¸²ÇÁÀý ÀýÁ¦¼ú;Àç¹ß
Rectal cancer;Total mesorectal excision;Lateral pelvic lymph node dissection;Recurrence

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS